Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117364) titled 'The role of recombinant human thrombin (Zepun) in hemostasis during vacuum-assisted breast nodule excision: a multicenter, prospective, randomized controlled study' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Women's Hospital, Zhejiang University School of Medicine
Condition:
Benign breast nodules
Intervention:
Experimental group:recombinant human thrombin (Zepun)
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-02-01
Target Sample Size: Experimental group:350;Control group:350;
Countries of Recruitment:
China
To know more, vis...